BridgeMD
New treatment option for Acute Insomnia Disorder
Official title Impact of Analytic-integrative Cognitive Behavioural Therapy on Acute Insomnia Disorder (Stress)
ClinicalTrials.gov ID: NCT06967922
What this study is testing
- What it's testing
- The main objective of this study, conducted in a population with acute insomnia disorder (stress), was to investigate the efficacy of Analytic-Integrative Cognitive Behavioural Therapy in the treatment of acute insomnia disorder (stress).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- meeting the DSM-5 diagnostic criteria for insomnia disorder;
- a total score of \>5 on the Pittsburgh Sleep Quality Index (PSQI);
- age ≥18 years old, with junior high school education or above;
- voluntarily participating in this study and signing an informed consent form;
- the diagnostic criteria for acute insomnia disorder (duration of the disease less than 3 months).
You likely can't join if
- people with comorbid serious physical or severe mental illnesses, suicide risk;
- clinically diagnosed or suspected sleep breathing disorder, restless legs syndrome and sleep-wake rhythm disorder, shift workers;
- pregnant and breastfeeding women;
- people who are currently undergoing any psychological treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.